ArticleBiomolecules2020

Preclinical Efficacy and Safety of an Anti-Human VEGFA and Anti-Human NRP1 Dual-Targeting Bispecific Antibody (IDB0076).

Jong-Hee Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.